live In the news:
Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump / Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad / Obesity drug sales surge at Novo Nordisk / Wegovy maker Novo Nordisk rebuked by watchdog over failure to disclose payments to UK health groups / London's FTSE 100 closes at record high; Novo Nordisk slides after U.S. lists its drugs for price talks / Ozempic could get cheaper as Medicare eyes drug price negotiations -- and Novo Nordisk stock slips / Novo Nordisk shares tumble as data on weight-loss drug trial disappoints / Novo Nordisk invests $1.2B to build new factory in Denmark / Novo Nordisk shares jump 8% after Wegovy sales beat expectations / Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

Novo Nordisk

7 days ago
bookmarkBookmark

Novo Nordisk is a company. It is in Bagsvaerd, Denmark and it has a male CEO called Lars Fruergaard Jorgensen. It was founded in 1923 and is part of the Health Care sector, specifically in the Biotechnology industry.

Key facts

plus See more facts
link LinkedIn: 1M followers
link X (Twitter): 47K followers


Extract data

Download datasets about Novo Nordisk:

dataset Dataset of stocks from Novo Nordisk:

Novo Nordisk is one of the companies in Biotechnology, companies in Health Care, companies in Bagsvaerd, companies in Denmark and 3,456,835 companies in our database.

Talking Points

  • Novo Nordisk | driving change to defeat serious chronic diseases
  • Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
  • Daily news about diabetes, obesity and other serious chronic diseases. We're global, but here in person for your questions and comments 💬 Community guide 👇
  • Driving change to defeat diabetes and other serious chronic diseases. Join us to learn more about our latest innovations | Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and ...
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
  • Apply online for jobs at Novo Nordisk

Related

Connected or similar to Novo Nordisk: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.